Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Hendricks

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Journal of Psychopharmacology (Oxford, England)|March 1, 2019
Prevalence and epidemiological associates of novel psychedelic use in the United States adult populationJames D Sexton, Michael S Crawford, Noah W Sweat, et al.
Criminal Behaviour and Mental Health : CBMH|June 10, 2014
Individuals in the criminal justice system show differences in cooperative behaviour: Implications from cooperative gamesBrendan C Clark, Christopher B Thorne, Peter S Hendricks, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic IndustryJacob S Aday, Brian S Barnett, Dan Grossman, et al.
American Journal of Preventive Medicine|June 21, 2015
Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice SmokersKaren L Cropsey, C Brendan Clark, Xiao Zhang, et al.
Addictive Behaviors|November 6, 2016
Predictors of medication adherence and smoking cessation among smokers under community corrections supervisionKaren L Cropsey, C Brendan Clark, Erin N Stevens, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|June 18, 2025
Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar DisordersHaley Maria Dourron, Melissa Bradley, Otto Simonsson, et al.
Journal of Psychopharmacology (Oxford, England)|March 7, 2022
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept studyNeiloufar Family, Peter S Hendricks, Luke Tj Williams, et al.
The International Journal on Drug Policy|July 30, 2021
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programsDavid B Yaden, Andrea P Berghella, Paul S Regier, et al.
Journal of Addiction Medicine|August 14, 2023
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH StudyRuoyan Sun, Sofia Mildrum Chana, Elizabeth Hawes, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance useZach Walsh, Peter S Hendricks, Stephanie Smith, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Journal of Psychopharmacology (Oxford, England)|March 1, 2019
Prevalence and epidemiological associates of novel psychedelic use in the United States adult populationJames D Sexton, Michael S Crawford, Noah W Sweat, et al.
Criminal Behaviour and Mental Health : CBMH|June 10, 2014
Individuals in the criminal justice system show differences in cooperative behaviour: Implications from cooperative gamesBrendan C Clark, Christopher B Thorne, Peter S Hendricks, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic IndustryJacob S Aday, Brian S Barnett, Dan Grossman, et al.
American Journal of Preventive Medicine|June 21, 2015
Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice SmokersKaren L Cropsey, C Brendan Clark, Xiao Zhang, et al.
Addictive Behaviors|November 6, 2016
Predictors of medication adherence and smoking cessation among smokers under community corrections supervisionKaren L Cropsey, C Brendan Clark, Erin N Stevens, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|June 18, 2025
Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar DisordersHaley Maria Dourron, Melissa Bradley, Otto Simonsson, et al.
Journal of Psychopharmacology (Oxford, England)|March 7, 2022
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept studyNeiloufar Family, Peter S Hendricks, Luke Tj Williams, et al.
The International Journal on Drug Policy|July 30, 2021
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programsDavid B Yaden, Andrea P Berghella, Paul S Regier, et al.
Journal of Addiction Medicine|August 14, 2023
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH StudyRuoyan Sun, Sofia Mildrum Chana, Elizabeth Hawes, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance useZach Walsh, Peter S Hendricks, Stephanie Smith, et al.
Pageof 15